London, UK and Phoenix, AZ (April 28, 2022)- AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the Company that he has recently purchased an additional 9,447 ACUT shares in the open market. This brings his total holding to 3,801,226 shares.

Gabriele Cerrone commented, “These open market share purchases of ACUT stock reflect my absolute confidence in what we are building at AccuStem. As the largest shareholder of AccuStem, my interests continue to be fully aligned with my fellow shareholders. I look forward to continuing to execute our plan to drive value for shareholders.”

About AccuStem

AccuStem is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology- to empower patients and their care team with critical answers and tools and drive innovation in healthcare.

Media Contact:

Jeff Fensterer

Phone: 415-640-6010

Email: [email protected]

Investor Contact:

Wendy Blosser

Email: [email protected]

View PDF Full Release

Contact us today

Thank you for your message. It has been sent.

There was an error trying to send your message. Please try again later.

Our Technology

We are building an ecosystem of products that will change how cancer is treated and managed.

Learn More